3D Tissue Models

This person is not registered. Is this you?


Profile Details
Shunlin Ren
Affiliations:

Virginia Commonwealth University

 
,
Phone: 23298-0678
Fax:
My Blogs:
My Twitter Hashtags:
@NUESTNEWS
 
Age:
Bio:
 
Specialty:
Cancer Immunotherapy
 
Presented at Events Covering:
, Biology, Cancer Biology, Cell Biology, Cytokine, Drug Design, Hepatology, Nephrology, Pathophysiology, Peptides, Stem Cells
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 8136 / 3501 (What's this?)
Accomplish Score: 14
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 243
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 1 (14 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 6 (36 / 0)
  • Purpose: Gastric cancer (GC), one of the world's top five most common cancers, is the third leading cause of cancer related death. ()
  • This study aimed to investigate the role of bevacizumab in patients with advanced non-small cell lung cancer (NSCLC) who had developed acquired resistance to EGFR-TKIs therapy that manifested as malignant pleural effusion (MPE). ()
  • BACKGROUND: Aimed to identify the benefit population from continuation of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), this study investigated the efficacy of continuation of EGFR-TKIs plus chemotherapy beyond the response evaluation criteria in solid tumors-progressive disease (RECIST-PD) according to different progression modes and T790M mutational status. ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.